Is a Vaccine for Multiple Myeloma Feasible?

A study presented at the American Association of Cancer Research (AACR) 2021 Annual Meeting found a personalized genomic cancer vaccine was feasible and well-tolerated in a phase 1 trial of patients with cancer, including multiple myeloma (MM). “While cancer immunotherapy has revolutionized the treatment of cancer, we know that the majority of patients fail to … Continue reading Is a Vaccine for Multiple Myeloma Feasible?